| Title |
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
|
|---|---|
| Published in |
Journal of Clinical Oncology, October 2011
|
| DOI | 10.1200/jco.2010.33.9549 |
| Pubmed ID | |
| Authors |
Peter Borchmann, Heinz Haverkamp, Volker Diehl, Thomas Cerny, Jana Markova, Anthony D. Ho, Hans-Theodor Eich, Hans Konrad Mueller-Hermelink, Lothar Kanz, Richard Greil, Andreas Rank, Ursula Paulus, Lenka Smardova, Christoph Huber, Bernd Dörken, Christoph Nerl, Stefan W. Krause, Rolf-Peter Mueller, Michael Fuchs, Andreas Engert |
| Abstract |
Eight cycles of BEACOPP(escalated) (escalated dose of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) followed by radiotherapy (RT) to initial bulk or residual tumor mass is the German Hodgkin Study Group standard of care for advanced-stage Hodgkin's lymphoma (HL). However, treatment-related toxicity is a concern, and the role of RT in this setting is unclear. The HD12 study thus aimed to reduce toxicity while maintaining efficacy. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Germany | 2 | 1% |
| Denmark | 1 | <1% |
| Unknown | 143 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 33 | 22% |
| Other | 28 | 19% |
| Student > Postgraduate | 14 | 9% |
| Professor > Associate Professor | 12 | 8% |
| Student > Bachelor | 10 | 7% |
| Other | 32 | 21% |
| Unknown | 20 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 66% |
| Agricultural and Biological Sciences | 5 | 3% |
| Nursing and Health Professions | 3 | 2% |
| Physics and Astronomy | 3 | 2% |
| Mathematics | 2 | 1% |
| Other | 9 | 6% |
| Unknown | 29 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2021.
All research outputs
#4,190,237
of 25,374,647 outputs
Outputs from Journal of Clinical Oncology
#8,447
of 22,046 outputs
Outputs of similar age
#22,994
of 148,453 outputs
Outputs of similar age from Journal of Clinical Oncology
#48
of 168 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,046 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.